News Agency
The Times

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering Nuclear Power to The Company’s Performance

  • Written by Media Outreach
HONG KONG SAR - Media OutReach - 20 June 2022 - On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China. An...

Read more: Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China,...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion